{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:32:14Z","timestamp":1789839134517,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40263-017-0481-5","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T07:18:52Z","timestamp":1512976732000},"page":"1083-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Clozapine and Gastrointestinal Hypomotility"],"prefix":"10.1007","volume":"31","author":[{"given":"Dan","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"481_CR1","first-page":"CD000059","volume":"2","author":"K Wahlbeck","year":"2000","unstructured":"Wahlbeck K, Cheine M, Essali MA. Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database Syst Rev. 2000;2:CD000059 (update in: Cochrane Database Syst Rev. 2009;1:CD000059).","journal-title":"Cochrane Database Syst Rev"},{"key":"481_CR2","first-page":"CD000966","volume":"2","author":"A Tuunainen","year":"2000","unstructured":"Tuunainen A, Wahlbeck K, Gilbody SM. Newer atypical antipsychotic medication versus clozapine for schizophrenia. Cochrane Database Syst Rev. 2000;2:CD000966.","journal-title":"Cochrane Database Syst Rev."},{"key":"481_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ajp.156.2.294","volume":"156","author":"AF Breier","year":"1999","unstructured":"Breier AF, Malhotra AK, Su TP, et al. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry. 1999;156:294\u20138.","journal-title":"Am J Psychiatry."},{"key":"481_CR4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.158.8.1305","volume":"158","author":"JM Azorin","year":"2001","unstructured":"Azorin JM, Spiegel R, Remington G, et al. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiatry. 2001;158:1305\u201313.","journal-title":"Am J Psychiatry."},{"key":"481_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-3223(99)00029-3","volume":"46","author":"RR Conley","year":"1999","unstructured":"Conley RR, Tamminga CA, Kelly DL, et al. Treatment-resistant schizophrenia patients respond to clozapine after olanzapine non-response. Biol Psychiatry. 1999;46:73\u20137.","journal-title":"Biol Psychiatry."},{"key":"481_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/jcp.0b013e3180d0a6d4","volume":"27","author":"O Agid","year":"2007","unstructured":"Agid O, Remington G, Kapur S, Arenovich T, Zipursky RB. Early use of clozapine for poorly responding first-episode psychosis. J Clin Psychopharmacol. 2007;27:369\u201373.","journal-title":"J Clin Psychopharmacol."},{"issue":"2","key":"481_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","volume":"166","author":"S Leucht","year":"2009","unstructured":"Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, Asenjo Lobos C, Schwarz S, Davis JM. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry. 2009;166(2):152\u201363.","journal-title":"Am J Psychiatry."},{"key":"481_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","volume":"209","author":"D Siskind","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British. J Psychiatry. 2016;209:385\u201392.","journal-title":"J Psychiatry."},{"key":"481_CR9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/acps.12621","volume":"134","author":"A Vanasse","year":"2016","unstructured":"Vanasse A, Blais L, Courteau J, Cohen AA, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Carrier JD, Delorme A. Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study. Acta Psychiatr Scand. 2016;134:374\u201384.","journal-title":"Acta Psychiatr Scand."},{"key":"481_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","volume":"73","author":"MT Samara","year":"2016","unstructured":"Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, Leucht S. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry. 2016;73:199\u2013210.","journal-title":"JAMA Psychiatry."},{"key":"481_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamapsychiatry.2015.2966","volume":"73","author":"JM Kane","year":"2016","unstructured":"Kane JM, Correll CU. The role of clozapine in treatment-resistant schizophrenia. JAMA Psychiatry. 2016;73:187\u20138.","journal-title":"JAMA Psychiatry."},{"issue":"11","key":"481_CR12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","volume":"72","author":"O Agid","year":"2011","unstructured":"Agid O, Arenovich T, Sajeev G, Zipursky RB, Kapur S, Foussias G, Remington G. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry. 2011;72(11):1439\u201344.","journal-title":"J Clin Psychiatry."},{"key":"481_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","volume":"36","author":"RW Buchanan","year":"2010","unstructured":"Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W, Schizophrenia Patient Outcomes Research Team (PORT). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71\u201393.","journal-title":"Schizophr Bull."},{"key":"481_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004714-199404000-00006","volume":"14","author":"F Centorrino","year":"1994","unstructured":"Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol. 1994;14:119\u201325.","journal-title":"J Clin Psychopharmacol."},{"key":"481_CR15","first-page":"298","volume":"152","author":"G Hayes","year":"1995","unstructured":"Hayes G, Gibler B. Clozapine-induced constipation. Am J Psychiatry. 1995;152:298.","journal-title":"Am J Psychiatry."},{"key":"481_CR16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00001648-199710000-00010","volume":"8","author":"AM Walker","year":"1997","unstructured":"Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8:661\u20137.","journal-title":"Epidemiology"},{"key":"481_CR17","first-page":"9","volume":"28","author":"PM Ellis","year":"2007","unstructured":"Ellis PM, McLean RM, Harrison-Woolrych M. Clozapine: fatal \u2018constipation\u2019 more common than fatal agranulocytosis. Prescr Update. 2007;28:9.","journal-title":"Prescr Update"},{"key":"481_CR18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4088\/JCP.v69n0509","volume":"69","author":"SE Palmer","year":"2008","unstructured":"Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry. 2008;69:759\u201368.","journal-title":"J Clin Psychiatry."},{"key":"481_CR19","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.forsciint.2010.07.021","volume":"206","author":"RJ Flanagan","year":"2011","unstructured":"Flanagan RJ, Ball RY. Gastrointestinal hypomotility: an under-recognised life-threatening adverse effect of clozapine. Forensic Sci Int. 2011;206:e31\u20136.","journal-title":"Forensic Sci Int."},{"key":"481_CR20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4088\/JCP.11r06977","volume":"73","author":"D Cohen","year":"2012","unstructured":"Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry. 2012;73:1307\u201312.","journal-title":"J Clin Psychiatry."},{"key":"481_CR21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-803376-0.00006-X","volume-title":"Life-threatening effects of antipsychotic drugs","author":"RJ Flanagan","year":"2016","unstructured":"Flanagan RJ, Ronaldson KJ. Gastrointestinal hypomotility and dysphagia. In: Manu P, Flanagan RJ, Ronaldson KJ, editors. Life-threatening effects of antipsychotic drugs. London: Academic Press; 2016. p. 151\u201379."},{"key":"481_CR22","doi-asserted-by":"crossref","unstructured":"Pajouhi P, Bourgeois JA. Clozapine, fluoxetine and benztropine-associated ileus: case report. Jefferson J Psychiatry. 2007;21(1): Article 1. http:\/\/jdc.jefferson.edu\/jeffjpsychiatry\/vol21\/iss1\/1 . Accessed 6 Dec 2017.","DOI":"10.29046\/JJP.021.1.001"},{"key":"481_CR23","first-page":"385","volume":"11","author":"E Lavi","year":"2009","unstructured":"Lavi E, Rivkin L, Carmon M, Reissma P. Clozapine-induced colonic obstruction requiring surgical treatment. Isr Med Assoc J. 2009;11:385\u20136.","journal-title":"Isr Med Assoc J."},{"key":"481_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/JCP.0b013e3181e71ee4","volume":"30","author":"C Mart\u00ednez D\u00edaz-Caneja","year":"2010","unstructured":"Mart\u00ednez D\u00edaz-Caneja C, Gonz\u00e1lez-Molinier M, Conejo Galindo J, Moreno I\u00f1iguez M. Severe bowel ischemia due to clozapine with complete remission after withdrawal. J Clin Psychopharmacol. 2010;30:463\u20135.","journal-title":"J Clin Psychopharmacol."},{"key":"481_CR25","first-page":"549","volume":"36","author":"M Prieto Peraita","year":"2012","unstructured":"Prieto Peraita M, Sanchez Marcosa MJ, et al. Possible ischemic colitis with clozapine. Farm Hosp. 2012;36:549.","journal-title":"Farm Hosp"},{"key":"481_CR26","doi-asserted-by":"publisher","unstructured":"Shah V, Anderson J. Clozapine-induced ischaemic colitis. BMJ Case Rep 2013. https:\/\/doi.org\/10.1136\/bcr-2012-007933 .","DOI":"10.1136\/bcr-2012-007933"},{"key":"481_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/2045125314524980","volume":"4","author":"B Cam","year":"2014","unstructured":"Cam B, Tanircan MZ. Clozapine-induced paralytic ileus: a case report. Ther Adv Psychopharmacol. 2014;4:170\u20132.","journal-title":"Ther Adv Psychopharmacol."},{"key":"481_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/acps.12259","volume":"130","author":"JM Meyer","year":"2014","unstructured":"Meyer JM, Cummings MA. Lubiprostone for treatment-resistant constipation associated with clozapine use. Acta Psychiatr Scand. 2014;130:71\u20132.","journal-title":"Acta Psychiatr Scand."},{"key":"481_CR29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5582\/ddt.2015.01067","volume":"9","author":"M Osseis","year":"2015","unstructured":"Osseis M, Lim C, Lahat E, Doussot A, Salloum C, Azoulay D. Hepatic venous outflow block caused by compressive fecaloma in a schizophrenic patient treated with clozapine. Drug Discov Ther. 2015;9:422\u20133.","journal-title":"Drug Discov Ther."},{"key":"481_CR30","first-page":"283","volume":"27","author":"H Sarac","year":"2015","unstructured":"Sarac H, Henigsberg N, Bagaric-Krakan L. Clozpaine-induced paralytic ileus. Psychiatr Danub. 2015;27:283\u20134.","journal-title":"Psychiatr Danub."},{"key":"481_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/IMCRJ.S86716","volume":"8","author":"V Oke","year":"2015","unstructured":"Oke V, Schmidt F, Bhattari B, Basunia M, Agu C, Kaur A, et al. Unrecognized clozapine-related constipation leading to fatal intra-abdominal sepsis\u2014a case report. Int Med Case Rep J. 2015;8:189\u201392.","journal-title":"Int Med Case Rep J."},{"key":"481_CR32","first-page":"44","volume":"44","author":"IM Castillo-Garcia","year":"2016","unstructured":"Castillo-Garcia IM, Maestro G, Puerta S, Ostos F, Nava P, Losada I. Clozapine-induced paralytic ileus. Actas Esp Psiquiatr. 2016;44:44\u20135.","journal-title":"Actas Esp Psiquiatr."},{"key":"481_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1039856215604487","volume":"24","author":"I Mohan","year":"2016","unstructured":"Mohan I, Wendelborn K. Constipation associated with clozapine: need for closer monitoring. Australas Psychiatry. 2016;24:97.","journal-title":"Australas Psychiatry."},{"key":"481_CR34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/pds.1801","volume":"18","author":"H Peyri\u00e8re","year":"2009","unstructured":"Peyri\u00e8re H, Roux C, Ferard C, Deleau N, Kreft-Jais C, Hillaire-Buys D, et al. Antipsychotic-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2009;18:948\u201355.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"481_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","volume":"173","author":"TS Stroup","year":"2016","unstructured":"Stroup TS, Gerhard T, Crystal S, Huang C, Olfson M. Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia. Am J Psychiatry. 2016;173:166\u201373 (supplemental table\u00a05 and 6).","journal-title":"Am J Psychiatry."},{"key":"481_CR36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/sbq137","volume":"38","author":"J Nielsen","year":"2012","unstructured":"Nielsen J, Meyer JM. Risk factors for ileus in patients with schizophrenia. Schizophr Bull. 2012;38:592\u20138.","journal-title":"Schizophr Bull."},{"key":"481_CR37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/JCP.0b013e31819a91f1","volume":"29","author":"M Ozbilen","year":"2009","unstructured":"Ozbilen M, Adams CE. Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs. J Clin Psychopharmacol. 2009;29:141\u20136.","journal-title":"J Clin Psychopharmacol."},{"key":"481_CR38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YIC.0b013e32819f8f17","volume":"22","author":"B Yusufi","year":"2007","unstructured":"Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, Barnes TRE. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol. 2007;22:238\u201343.","journal-title":"Int Clin Psychopharmacol."},{"key":"481_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/ijms17060863","volume":"17","author":"A Shirazi","year":"2016","unstructured":"Shirazi A, Stubbs B, Gomez L, Moore S, Gaughran F, Flanagan RJ. Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis. Int J Mol Sci. 2016;17:863. https:\/\/doi.org\/10.3390\/ijms17060863 .","journal-title":"Int J Mol Sci."},{"key":"481_CR40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.schres.2015.05.025","volume":"166","author":"T Baptista","year":"2015","unstructured":"Baptista T, Carrizo E, Fernandez E, Connell L, Servigna M, Parra A, et al. Colonic transit diagnostic test shows significant gastrointestinal hypomotility in clozapine-treated patients in comparison with subjects treated with other antipsychotics. Schizophr Res. 2015;166:207\u201311.","journal-title":"Schizophr Res."},{"key":"481_CR41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ebiom.2016.02.020","volume":"5","author":"S Every-Palmer","year":"2016","unstructured":"Every-Palmer S, Nowitz M, Stanley J, Grant E, Huthaite M, Dunn H, et al. Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study. EBioMedicine. 2016;5:125\u201334.","journal-title":"EBioMedicine."},{"key":"481_CR42","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.pnpbp.2010.07.013","volume":"34","author":"S Berger","year":"2010","unstructured":"Berger S, Hocke M, B\u00e4r K. Gastric dysmotility in healthy first-degree relatives of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1294\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"481_CR43","unstructured":"Rome criteria functional constipation. Attachment A, p 890, C3. http:\/\/www.romecriteria.org\/assets\/pdf\/19_RomeIII_apA_885-898.pdf . Accessed 6 Dec 2017."},{"key":"481_CR44","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form as a useful guide to intestinal transit time. Scand J Gastorenterol. 1997;32:920\u20134.","journal-title":"Scand J Gastorenterol."},{"key":"481_CR45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08039488.2016.1217044","volume":"71","author":"T Virtanen","year":"2017","unstructured":"Virtanen T, Eskelinen S, Sailas E, Suvisaari J. Dyspepsia and constipation in patients with schizophrenia spectrum disorders. Nord J Psychiatry. 2017;71:48\u201354.","journal-title":"Nord J Psychiatry."},{"key":"481_CR46","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.euroneuro.2016.08.004","volume":"26","author":"C Lemogne","year":"2016","unstructured":"Lemogne C, Nebot N, Blondon H, Roux P. Systematic prevention of severe constipation induced by antipsychotic agents: a quasi-experimental study. Eur Neuropsychopharmacol. 2016;26:1690\u20131.","journal-title":"Eur Neuropsychopharmacol"},{"key":"481_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40263-016-0391-y","volume":"31","author":"S Every-Palmer","year":"2017","unstructured":"Every-Palmer S, Ellis PM, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H. The porirua protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: a pre- and post-treatment study. CNS Drugs. 2017;31:75\u201385.","journal-title":"CNS Drugs."},{"key":"481_CR48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.jcp.0000085405.08426.73","volume":"23","author":"J Leon de","year":"2003","unstructured":"de Leon J, Odom-White A, Josiassen RC, Diaz FJ, Cooper TB, Simpson GM. Serum antimuscarinic activity during clozapine treatment. J Clin Psychopharmacol. 2003;23:336\u201341.","journal-title":"J Clin Psychopharmacol."},{"issue":"11","key":"481_CR49","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.euroneuro.2013.05.001","volume":"23","author":"PM Bet","year":"2013","unstructured":"Bet PM, Hugtenburg JG, Penninx BW, Hoogendijk WJ. Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol. 2013;23(11):1443\u20135.","journal-title":"Eur Neuropsychopharmacol."},{"key":"481_CR50","doi-asserted-by":"publisher","first-page":"CD011128","DOI":"10.1002\/14651858.CD011128.pub2","volume":"1","author":"S Every-Palmer","year":"2017","unstructured":"Every-Palmer S, Newton-Howes G, Clarke MJ. Pharmacological treatment for antipsychotic-related constipation. Cochrane Database Syst Rev. 2017;1:CD011128. https:\/\/doi.org\/10.1002\/14651858.CD011128.pub2 .","journal-title":"Cochrane Database Syst Rev."},{"key":"481_CR51","unstructured":"NHG Standaard Obstipatie (Dutch)\u00a0=\u00a0Drug therapy of constipation. Organization of Dutch general practitioners. https:\/\/www.nhg.org\/standaarden\/volledig\/nhg-standaard-obstipatie . Accessed 6 Dec 2017."},{"key":"481_CR52","unstructured":"Schwartz D. Drug Information Pharmacist, Graylands Health Service. North Metropolitan Health Service, Mental Health, Perth, Western Australia. Personal communication."},{"key":"481_CR53","unstructured":"Veterans\u2019 Mates. Australian Government, Department of Veterans\u2019 Affairs. Opioid-induced constipation: a preventable problem. https:\/\/www.veteransmates.net.au\/topic-27-therapeutic-brief . Accessed 6 Dec 2017."},{"key":"481_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/YIC.0b013e32835b08d2","volume":"28","author":"E Chukhin","year":"2013","unstructured":"Chukhin E, Takala P, Hakko H, Raidma M, Putkonen H, R\u00e4s\u00e4nen P, Terevnikov V, Stenberg JH, Eronen M, Joffe G. In a randomized placebo-controlled add-on study orlistat significantly reduced clozapine-induced constipation. Int Clin Psychopharmacol. 2013;28:67\u201370.","journal-title":"Int Clin Psychopharmacol."},{"key":"481_CR55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/JCP.0b013e3182a1160d","volume":"33","author":"CE Poetter","year":"2013","unstructured":"Poetter CE, Stewart JT. Treatment of clozapine-induced constipation with bethanechol. J Clin Psychopharmacol. 2013;33:713\u20134.","journal-title":"J Clin Psychopharmacol."},{"key":"481_CR56","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3109\/00365529709002985","volume":"32","author":"A Glia","year":"1997","unstructured":"Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997;32:1083\u20139.","journal-title":"Scand J Gastroenterol."},{"key":"481_CR57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0399-8320(04)94835-X","volume":"28","author":"H Damon","year":"2004","unstructured":"Damon H, Dumas P, Mion F. Impact of anal incontinence and chronic constipation on quality of life. Gastroenterol Clin Biol. 2004;28:16\u201320.","journal-title":"Gastroenterol Clin Biol."},{"key":"481_CR58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2036.2007.03376.x","volume":"26","author":"A Wald","year":"2007","unstructured":"Wald A, Scarpignato C, Kamm MA, Mueller-Lissner S, Helfrich I, Schuijt C, Bubeck J, Limoni C, Petrini O. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227\u201336.","journal-title":"Aliment Pharmacol Ther."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-017-0481-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T04:43:16Z","timestamp":1660106596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-017-0481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s40263-017-0481-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}